GOLDMAN SACHS GROUP INC - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 160 filers reported holding CONMED CORP in Q4 2017. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$35,984,216
-27.4%
356,809
-2.2%
0.01%
-30.0%
Q2 2023$49,590,368
+11.6%
364,930
-14.7%
0.01%
+11.1%
Q1 2023$44,435,064
+33.6%
427,836
+14.0%
0.01%
+28.6%
Q4 2022$33,270,766
-17.9%
375,347
-25.7%
0.01%
-22.2%
Q3 2022$40,513,000
-14.3%
505,340
+2.3%
0.01%
-18.2%
Q2 2022$47,298,000
-44.8%
493,919
-14.3%
0.01%
-38.9%
Q1 2022$85,619,000
-1.1%
576,366
-5.6%
0.02%
+5.9%
Q4 2021$86,534,000
+23.7%
610,421
+14.2%
0.02%
+13.3%
Q3 2021$69,928,000
+7.0%
534,488
+12.4%
0.02%0.0%
Q2 2021$65,356,000
-9.8%
475,560
-14.3%
0.02%
-16.7%
Q1 2021$72,450,000
+14.3%
554,789
-2.0%
0.02%
+12.5%
Q4 2020$63,412,000
+54.5%
566,174
+8.5%
0.02%
+33.3%
Q3 2020$41,038,000
+0.2%
521,655
-8.3%
0.01%0.0%
Q2 2020$40,970,000
+35.8%
569,111
+8.0%
0.01%
+9.1%
Q1 2020$30,169,000
-46.9%
526,799
+3.6%
0.01%
-21.4%
Q4 2019$56,861,000
+12.1%
508,463
-3.6%
0.01%
-6.7%
Q3 2019$50,735,000
-9.4%
527,671
-19.3%
0.02%
-6.2%
Q2 2019$55,985,000
-17.0%
654,253
-19.3%
0.02%
-20.0%
Q1 2019$67,449,000
+28.2%
810,876
-1.1%
0.02%
+17.6%
Q4 2018$52,622,000
-19.7%
819,651
-0.9%
0.02%0.0%
Q3 2018$65,504,000
+12.6%
826,860
+4.0%
0.02%
+6.2%
Q2 2018$58,182,000
+3.6%
794,833
-10.4%
0.02%
+14.3%
Q1 2018$56,168,000
+3.2%
886,916
-16.9%
0.01%
+7.7%
Q4 2017$54,401,000
+3.1%
1,067,319
+6.1%
0.01%0.0%
Q3 2017$52,769,000
+6.0%
1,005,702
+2.9%
0.01%0.0%
Q2 2017$49,797,000
+11.3%
977,564
-2.9%
0.01%
+8.3%
Q1 2017$44,728,000
-3.1%
1,007,160
-3.6%
0.01%
-7.7%
Q4 2016$46,156,000
+19.8%
1,044,978
+8.7%
0.01%
+8.3%
Q3 2016$38,526,000
-16.6%
961,701
-0.6%
0.01%
-20.0%
Q2 2016$46,197,000
+11.2%
967,883
-2.3%
0.02%
+7.1%
Q1 2016$41,546,000
+94.0%
990,609
+103.8%
0.01%
+100.0%
Q4 2015$21,416,000
+2225.3%
486,186
+2420.3%
0.01%
Q3 2015$921,000
+138.6%
19,291
+191.1%
0.00%
Q2 2015$386,000
-81.7%
6,627
-84.2%
0.00%
-100.0%
Q1 2015$2,112,000
+604.0%
41,832
+527.7%
0.00%
Q4 2014$300,000
-83.9%
6,664
-86.8%
0.00%
-100.0%
Q3 2014$1,863,000
-36.5%
50,579
-23.8%
0.00%0.0%
Q2 2014$2,932,000
+603.1%
66,399
+591.9%
0.00%
Q1 2014$417,000
-83.4%
9,597
-83.8%
0.00%
-100.0%
Q4 2013$2,511,000
+93.8%
59,081
+54.8%
0.00%
Q3 2013$1,296,000
-16.7%
38,167
-23.3%
0.00%
-100.0%
Q2 2013$1,555,000
-59.1%
49,789
-63.4%
0.00%
-50.0%
Q4 2012$3,804,000
+24.8%
136,116
+27.2%
0.00%
+100.0%
Q3 2012$3,049,000
+61.3%
106,992
+56.6%
0.00%0.0%
Q2 2012$1,890,000
+230.4%
68,321
+257.0%
0.00%
Q1 2012$572,00019,1360.00%
Other shareholders
CONMED CORP shareholders Q4 2017
NameSharesValueWeighting ↓
Iron Triangle Partners LP 190,000$24,858,0003.57%
Ranger Investment Management 253,789$33,203,0001.77%
EARNEST PARTNERS LLC 1,603,130$209,737,0001.28%
Penn Capital Management Company, LLC 92,086$12,048,0001.22%
Champlain Investment Partners, LLC 1,492,419$195,253,0000.94%
MOODY ALDRICH PARTNERS LLC 53,257$6,968,0000.88%
Hood River Capital Management LLC 215,384$28,179,0000.87%
OAK RIDGE INVESTMENTS LLC 71,880$9,404,0000.83%
WAFRA INC. 138,542$18,125,0000.66%
EPIQ PARTNERS, LLC 10,463$1,369,0000.63%
View complete list of CONMED CORP shareholders